We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Lichen-Derived Dye May Prevent Alzheimer’s by Neutralizing Toxic Peptides

By LabMedica International staff writers
Posted on 14 Dec 2011
A dye derived from lichens is among the candidate compounds being tested for their ability to convert toxic prefibrillar assemblies of amyloid-beta (A-beta) polypeptides – the cause of neuron death in Alzheimer’s disease – into mature, end-stage amyloid fibrils that are thought to be largely nontoxic.

The dye under consideration by investigators at the Max Delbruck Center for Molecular Medicine (Berlin, Germany) is called O4. More...
This compound is a blue dye that was isolated from lichens together with the reddish-brown dye orcein.

The investigators reported in the November 20, 2011, issue of the journal Nature Chemical Biology that O4 directly bound to hydrophobic amino acid residues in A-beta peptides and stabilized the self-assembly of beta-sheet-rich protofibrils and fibrils. The O4-mediated acceleration of amyloid fibril formation efficiently decreased the concentration of small, toxic A-beta oligomers in complex, heterogeneous aggregation reactions.

O4 treatment suppressed inhibition of long-term potentiation by A-beta oligomers in hippocampal brain slices, results that support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.

“This is a new mechanism,” said senior author Dr. Erich Wanker, professor of neuroproteomics at the Max Delbruck Center for Molecular Medicine. “Up to now it has been considered to be very difficult to stop the formation of small toxic protein assemblies. If our hypothesis is correct that the small aggregates, which are precursors of plaques, indeed cause neuronal death, with O4 we would have a new mechanism to attack the disease. We hope that our findings will stimulate research activities in this direction, especially in drug discovery.”

Related Links:

Max Delbruck Center for Molecular Medicine



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Thyroid Test
Anti-Thyroid EIA Test
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers identified 157 metabolites linked to BBB damage, including 25 that appeared in at least two independent studies (Image Credit: Adobe Stock)

Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury

Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.